Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Revatio (sildenafil) in adults with pulmonary arterial hypertension (AFFILIATE)
NCT02060487Phase 4Terminated
- Sponsor
- Viatris
- Start
- Sep 2014
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 23
01
Overview
A Phase 4 trial of ASP-001 in pulmonary arterial hypertension (PAH), sponsored by Viatris. Started Sep 2014; status: terminated.
02
Drugs
ASP-001
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT02060487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02060487.